BIOXYTRAN, INC
Bioxytran is a clinical stage pharmaceutical company developing platform technologies in the fields of Glycovirology, Hypoxia and Degenerative Diseases. They aim to eliminate viruses and prolong lifespan using carbohydrate drug design, utilizing Galectin inhibitors to combat viruses like SARS-CoV-2. The company is also developing treatments for hypoxic conditions, necrosis, and degenerative diseases, leveraging oxygen transport to affected areas.
Official Registry
AI Quality Analysis
Trust Score Breakdown
Quick Links
Website Highlights
🌟 Similar Trusted Businesses
Addex Therapeutics Ltd.
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Their pipeline includes compounds targeting post-stroke recovery, substance use disorder and chronic cough. The company utilizes its expertise in allosteric modulation for drug discovery.
SciSparc Ltd.
SciSparc is a specialty pharmaceutical company developing unique cannabinoid technologies for the treatment of central nervous system disorders. Their pipeline includes drug candidates in clinical trials for Tourette Syndrome, Obstructive Sleep Apnea, Alzheimer’s Disease, Agitation, and Autism Spectrum Disorder. The company focuses on improving the lives of those suffering from central nervous system disorders.
SERVIER OUTRE-MER
Servier is an independent international pharmaceutical company focused on therapeutic progress for patients. They invest significantly in research and development, particularly in oncology, cardiometabolism, and neuroscience. Servier is known for its long-term vision and commitment to patients' needs.